Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Migraine & Headache

Atogepant Under Review for Episodic Migraine Prevention

Diana Ernst, RPh

April 5, 2021

Atogepant is an investigational orally administered calcitonin gene-related peptide (CGRP) receptor antagonist.

Musculoskeletal Pain

FDA Panel Votes on Tanezumab for Osteoarthritis Pain

Diana Ernst, RPh

March 31, 2021

Tanezumab is a humanized monoclonal antibody that selectively targets, binds to, and inhibits nerve growth factor.

Acute Pain

FDA Expands Use of ClearUp Bioelectronic Pain Device to Ease Sinus Congestion

Diana Ernst, RPh

March 30, 2021

The bioelectronic device was previously approved for treating sinus pain due to allergic rhinitis.

General Pain

FDA Cracks Down on Companies Selling Unapproved CBD Products

Diana Ernst, RPh

March 29, 2021

The products described in the warning letters are being marketed as topical pain therapies, though none have actually been evaluated by the FDA.

Practice Management

AstraZeneca COVID-19 Vaccine 79% Effective, According to US Trial Data

Diana Ernst, RPh

March 26, 2021

AZD1222 utilizes a replication-deficient chimpanzee adenovirus to deliver a SARS-CoV-2 protein to induce a protective immune response.

Practice Management

Pediatric Trial Evaluating Moderna’s COVID-19 Vaccine Begins

Diana Ernst, RPh

March 19, 2021

The phase 2/3 KidCOVE study is evaluating the safety and effectiveness of the vaccine in healthy children between 6 months and less than 12 years of age.

Practice Management

CDC Provides Guidance for Individuals Fully Vaccinated Against COVID-19

Diana Ernst, RPh

March 10, 2021

Fully vaccinated individuals can visit with other fully vaccinated people, or unvaccinated people from a single household who are at low risk for severe COVID-19 disease, indoors without wearing masks or physical distancing.